National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

DATE > Friday, October 6, 2017  > Enroll Now!

LOCATION > Hilton San Francisco Union Square • San Francisco, California

 

Early bird discounts expire on Friday, September 8

OVERVIEW

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the global oncology space, its future and its current operational issues from the provider, payer, and patient advocate perspective. Participants will improve their working knowledge of key global business, policy, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in consideration of worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships.

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.


MODERATOR

Robert W. Carlson, MD 
National Comprehensive Cancer Network

CURRICULUM*

8:00 – 8:25 AM              
Breakfast

8:25 – 8:30 AM
Opening Remarks
C. Lyn Fitzgerald, MJ
Senior Vice President, U.S. & Global Development
National Comprehensive Cancer Network

8:35 – 8:40 AM
NCCN Global Impact
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

8:45 – 10:10 AM
Module I: Regional Adaptations - Meet NCCN Guidelines Panel and Collaborative International Experts

Panelists:

David S. Ettinger, MD / Chair, Imaging Reviewer Professor of Oncology
Chair, NCCN Guidelines for Non-Small Cell Lung Cancer, MPM, and Thymomas Panels
Member, NCCN Guidelines for Antiemesis and Lung Cancer Screening Panels
Chair, Guideline Steering Committee
Member, International Program Steering Committee
Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins

Pere Gascon, MD
Head of Medical Oncology University Hospital
NCCN Guideline for Breast Cancer Collaborative International Expert
La Fundación para la Excelencia y la Calidad en la Oncología
Barcelona, España

William J. Gradishar, MD / Chair, Imaging Reviewer
Betsy Bramsen Professor of Breast Oncology, Director,
Maggie Daley Center for Women`s Cancer Care,
Director, Breast Medical Oncology
Chair, NCCN Guidelines for Breast Cancer Panel
Member, NCCN Guidelines for Breast Cancer Risk Reduction Panel
Member, International Program Steering Committee
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University

James L. Mohler, MD / Chair, Imaging Reviewer
Associate Director and Senior Vice President for
Translational Research, Chair, Department of Urology
Chair, NCCN Guidelines for Prostate Cancer Panel
Member, NCCN Guidelines for Prostate Cancer Early Detection Panel
Roswell Park Cancer Institute

Fábio Schütz, MD
Beneficência Portuguesa de São Paulo – Centro Oncologico Antonio Ermírio de Moraes
NCCN Guidelines for Prostate Cancer Collaborative International Expert
Hospital São José Centro Avançado de Oncologia
Sao Paulo, Brazil   

10:10 – 10:25 AM
Break

10:30 – 11:55 AM
Module II: Global Patient Advocacy and Policy

Panelists:
Marcia Horn
President and CEO
International Cancer Advocacy Network (ICAN)

Mihaela Militaru
Senior Director
EU Patient Advocacy & Strategic Partnerships, Oncology
EMD Serono

Cathy Trzaskawka
Head, Global Advocacy
Global Policy, Advocacy & Government Affairs
Bristol-Myers Squibb

Karen Van Rassel
CEO
Lymphoma Coalition
Ontario, Canada

Piotr Wysocki MD, PhD
Professor of Medicine – Clinical Oncology
Head of Chair and Department of Oncology
Jagiellonian University – Medical College Hospital
President of Polish Society of Clinical Oncology

11:55 AM – 12:00 PM
Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Curriculum subject to change.


PROGRAM LOCATION

Hilton San Francisco Union Square
333 O'Farrell Street
San Francisco, CA 94102

INTENDED AUDIENCE

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas.

TUITION

By 9.8.17 After 9.8.17

Academy Alumni

$399 $599

All Industry Registrants

$599 $855

NCCN Corporate Council Member

$559 $799

Ten or more people from the same company

$499 $699

ACCOMODATIONS

A block of rooms has been reserved at the Hilton San Francisco Union Square. You may book rooms by calling 1.415.771.1400. A special rate of $269.00 per night has been established for NCCN attendees. Please book your room by Tuesday, September 5, 2017 to take advantage of the discounted rate.

Early booking is strongly encouraged as the block may sell out before the September 5, 2017 cut-off date.

Make sure to reference NCCN when booking your room! You must be registered for the Academy to book a hotel room.


Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.


Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.